Matches in Nanopublications for { ?s ?p "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843353.RAizdz0yyuVL7preba6HaciuTVzzhMy8FNx1U5274FSkA130_provenance.
- NP870865.RAueN3WwMpyo3cM092KrUDxsgRZ7gXJ33tooxt-_jgjd4130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870865.RAueN3WwMpyo3cM092KrUDxsgRZ7gXJ33tooxt-_jgjd4130_provenance.
- NP670151.RA4Iq7AUqQV4Y71ws1HFe7fCHB_6dRMIq7OOtusL8BUH4130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670151.RA4Iq7AUqQV4Y71ws1HFe7fCHB_6dRMIq7OOtusL8BUH4130_provenance.
- NP1019664.RA4Xut_AwVFoGHYB5PxxzT_OJ17Lx-IaeNegUOtmgZpy4130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1019664.RA4Xut_AwVFoGHYB5PxxzT_OJ17Lx-IaeNegUOtmgZpy4130_provenance.
- assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP539571.RAolPpSDQ3RgHU51zUNiwmspnpnlV7Kv6bM6OjyGhZXrg130_assertion description "[In conclusion, we confirmed that fasting B48 is an independent marker of PAD in patients with DM2, unrelated to the preheparin LPL mass, statin therapy or glucose lowering treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539571.RAolPpSDQ3RgHU51zUNiwmspnpnlV7Kv6bM6OjyGhZXrg130_provenance.